ACCESSION: MSBNK-SMB_Measured-HSA001P0111024
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 102
COMMENT: RAW_SPEC {'BLK02_6506': {'bp': 939092.0, 'sum': 1428979.0}, '9_posi_6404': {'bp': 521285.0, 'sum': 989889.0}, '9_posi_6508': {'bp': 526645.0, 'sum': 972950.0}, '13_posi_6089': {'bp': 542232.0, 'sum': 1009111.0}, '3_posi_6131': {'bp': 631194.0, 'sum': 1120598.0}, '4_posi_5918': {'bp': 634072.0, 'sum': 1138734.0}, '3_posi_5917': {'bp': 650003.0, 'sum': 1134116.0}, '2_posi_6445': {'bp': 673648.0, 'sum': 1163845.0}, '2_posi_6170': {'bp': 705019.0, 'sum': 1251823.0}, 'BLK02_5979': {'bp': 775836.0, 'sum': 1295882.0}, '9_posi_6151': {'bp': 539281.0, 'sum': 1017182.0}, '12_posi_5942': {'bp': 547292.0, 'sum': 1040313.0}, '11_posi_5878': {'bp': 566205.0, 'sum': 1081619.0}, '8_posi_6340': {'bp': 579554.0, 'sum': 1080506.0}, '3_posi_6294': {'bp': 627692.0, 'sum': 1112568.0}, '3_posi_6464': {'bp': 631131.0, 'sum': 1114437.0}, '3_posi_6005': {'bp': 644572.0, 'sum': 1140564.0}, '1_posi_6213': {'bp': 735857.0, 'sum': 1239135.0}, 'ProcedureBlank_6001': {'bp': 760796.0, 'sum': 1212961.0}, 'ProcedureBlank_6084': {'bp': 771530.0, 'sum': 1236248.0}, 'BLK02_5898': {'bp': 776643.0, 'sum': 1257321.0}, '1_posi_5772': {'bp': 788539.0, 'sum': 1342057.0}, 'BLK02_6170': {'bp': 849441.0, 'sum': 1343713.0}, 'BLK02_6421': {'bp': 873668.0, 'sum': 1352879.0}, '13_posi_5898': {'bp': 476221.0, 'sum': 886807.0}, '13_posi_6425': {'bp': 506716.0, 'sum': 944552.0}, '15_posi_6508': {'bp': 518556.0, 'sum': 971480.0}, '19_posi_6299': {'bp': 519766.0, 'sum': 1000084.0}, '5_posi_5938': {'bp': 600189.0, 'sum': 1148759.0}, '6_posi_6233': {'bp': 603754.0, 'sum': 1053513.0}, '1_posi_6379': {'bp': 698565.0, 'sum': 1219964.0}, '1_posi_5962': {'bp': 706102.0, 'sum': 1188374.0}, '11_posi_6382': {'bp': 536982.0, 'sum': 980829.0}, '15_posi_6131': {'bp': 556904.0, 'sum': 1048041.0}, '9_posi_5898': {'bp': 577382.0, 'sum': 1105712.0}, '6_posi_6400': {'bp': 584620.0, 'sum': 1067688.0}, '4_posi_6067': {'bp': 608051.0, 'sum': 1087815.0}, '2_posi_6086': {'bp': 669652.0, 'sum': 1186670.0}, '2_posi_6004': {'bp': 707044.0, 'sum': 1213922.0}, 'BLK02_5816': {'bp': 743733.0, 'sum': 1242655.0}, '14_posi_6341': {'bp': 525540.0, 'sum': 1004027.0}, '16_posi_5816': {'bp': 528394.0, 'sum': 1102372.0}, '7_posi_6256': {'bp': 539470.0, 'sum': 997436.0}, '6_posi_6319': {'bp': 579425.0, 'sum': 1020623.0}, '10_posi_5920': {'bp': 605384.0, 'sum': 1153264.0}, '3_posi_6381': {'bp': 618513.0, 'sum': 1087233.0}, '2_posi_6256': {'bp': 719478.0, 'sum': 1286873.0}, '2_posi_5857': {'bp': 729757.0, 'sum': 1304672.0}, '1_posi_6126': {'bp': 738335.0, 'sum': 1218707.0}, '11_posi_6488': {'bp': 516875.0, 'sum': 930288.0}, '11_posi_6068': {'bp': 518907.0, 'sum': 987695.0}, '11_posi_5963': {'bp': 548395.0, 'sum': 1020152.0}, '8_posi_6422': {'bp': 553084.0, 'sum': 1004370.0}, '6_posi_6110': {'bp': 581542.0, 'sum': 1037125.0}, 'ProcedureBlank_5837': {'bp': 716784.0, 'sum': 1170001.0}, 'ProcedureBlank_6506': {'bp': 797581.0, 'sum': 1288951.0}, '17_posi_6257': {'bp': 467049.0, 'sum': 904704.0}, '14_posi_6233': {'bp': 531914.0, 'sum': 1042679.0}, '16_posi_6422': {'bp': 445474.0, 'sum': 915710.0}, '6_posi_6484': {'bp': 580846.0, 'sum': 1070994.0}, '8_posi_5856': {'bp': 601783.0, 'sum': 1128526.0}, '2_posi_5773': {'bp': 687361.0, 'sum': 1267194.0}, '1_posi_6463': {'bp': 739374.0, 'sum': 1265542.0}, '5_posi_6299': {'bp': 623435.0, 'sum': 1098559.0}, '8_posi_6215': {'bp': 550278.0, 'sum': 1020251.0}, '9_posi_6004': {'bp': 547232.0, 'sum': 1013103.0}, '7_posi_6425': {'bp': 530602.0, 'sum': 977574.0}, '14_posi_6487': {'bp': 529765.0, 'sum': 1035449.0}, 'BLK02_6340': {'bp': 853230.0, 'sum': 1367566.0}, 'ProcedureBlank_6422': {'bp': 825042.0, 'sum': 1281586.0}, 'ProcedureBlank_6339': {'bp': 821301.0, 'sum': 1329865.0}, 'BLK02_6088': {'bp': 804625.0, 'sum': 1283629.0}, '1_posi_6045': {'bp': 740717.0, 'sum': 1250125.0}, '1_posi_6292': {'bp': 729219.0, 'sum': 1191561.0}, '5_posi_6485': {'bp': 572998.0, 'sum': 1042828.0}, '6_posi_5816': {'bp': 562682.0, 'sum': 1041506.0}, '9_posi_6275': {'bp': 560068.0, 'sum': 1046732.0}, '13_posi_5984': {'bp': 556696.0, 'sum': 1022923.0}, '10_posi_5837': {'bp': 523653.0, 'sum': 1040730.0}, 'BLK02_6253': {'bp': 847082.0, 'sum': 1346929.0}, 'ProcedureBlank_5916': {'bp': 778589.0, 'sum': 1216481.0}, '1_posi_5855': {'bp': 730002.0, 'sum': 1222952.0}, '4_posi_6420': {'bp': 653150.0, 'sum': 1155011.0}, '5_posi_5771': {'bp': 617671.0, 'sum': 1169253.0}, '7_posi_5962': {'bp': 568382.0, 'sum': 1051348.0}, '18_posi_5816': {'bp': 517992.0, 'sum': 1075173.0}, 'ProcedureBlank_6171': {'bp': 773538.0, 'sum': 1243034.0}, '2_posi_6338': {'bp': 713001.0, 'sum': 1242465.0}, '4_posi_6296': {'bp': 629450.0, 'sum': 1128375.0}, '3_posi_6211': {'bp': 621346.0, 'sum': 1105244.0}, '4_posi_6507': {'bp': 614703.0, 'sum': 1107356.0}, '8_posi_5962': {'bp': 563695.0, 'sum': 1081262.0}, '12_posi_6403': {'bp': 546352.0, 'sum': 1008321.0}, '7_posi_5874': {'bp': 543978.0, 'sum': 1055458.0}, '19_posi_6045': {'bp': 514030.0, 'sum': 1037617.0}, '5_posi_6380': {'bp': 625071.0, 'sum': 1141968.0}, '5_posi_6151': {'bp': 583469.0, 'sum': 1046367.0}, '5_posi_5857': {'bp': 579258.0, 'sum': 1040847.0}, 'ProcedureBlank_6250': {'bp': 812813.0, 'sum': 1308825.0}, '6_posi_5899': {'bp': 626109.0, 'sum': 1110257.0}, '5_posi_6025': {'bp': 592506.0, 'sum': 1061973.0}, '4_posi_5837': {'bp': 615686.0, 'sum': 1132357.0}}
COMMENT: RETENTION_TIME_STDEV 0.459
COMMENT: PRECURSOR_M/Z_RAW 111.091736
COMMENT: PRECURSOR_M/Z_STDEV 0.000029
COMMENT: PRECURSOR_IN_MS1 mz 111.091684; int 129.960; delta(ppm) 1.474938
COMMENT: PROPOSED_CHARGE_STATE +1; mz 112.095006; int 7.822; cor 0.748
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 70.065194; int 15.865; cor 0.827
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+NH4; mz 87.091679; int 580.545; cor 0.898
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 70.065194; int 15.865; cor 0.827
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 70.065194; int 15.865; cor 0.827
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.055; C6H10N2; [M+H]+; delta(ppm) 0.054504
COMMENT: PROPOSED_MF SevenGoldenRules 0.116; C4H7N; [M+ACN+H]+; delta(ppm) 0.115845
COMMENT: PROPOSED_MF SevenGoldenRules 0.357; C2H4; [M+2ACN+H]+; delta(ppm) 0.356744
COMMENT: PROPOSED_MF MS-FINDER 4.306; C4H7N; [M+ACN+H]+; delta(ppm) 156383.489871
COMMENT: PROPOSED_MF MS-FINDER 4.119; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.095; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.484; C2H4; [M+C4H6N2+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.484; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.484; C4H7N; [M+C2H3N+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C2H4; [M+C4H6N2+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H10N2; [M+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N; [M+C2H3N+H]+; delta(ppm) 0.047117
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.200; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; N1=NC2CCC1CC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.582; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; CCC1=NC=C(C)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.525; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; CCCC1=CC=NN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; N[C]1[CH][CH][C]([CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; N[C]1[C]([CH][CH][CH][NH2+]1)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.393; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.306; ZVJHJDDKYZXRJI-UHFFFAOYSA-N; [M+ACN+H]+; 1-Pyrroline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.185; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.185; VTNUQSAAFBRENH-UHFFFAOYSA-N; [M+H]+; 1,2-dimethyl-1??-pyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.181; KVNRLNFWIYMESJ-UHFFFAOYSA-N; [M+ACN+H]+; butyronitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.143; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.108; SQRSDAJKJORZLJ-UHFFFAOYNA-N; [M+ACN+H]+; 2-vinylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.098; LRDFRRGEGBBSRN-UHFFFAOYSA-N; [M+ACN+H]+; isobutyronitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.098; RSEBUVRVKCANEP-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrroline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.025; FFDKYFGBIQQMSR-UHFFFAOYSA-N; [M+ACN+H]+; N-Propyl Isocyanide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.941; XSBPYGDBXQXSCU-UHFFFAOYSA-N; [M+ACN+H]+; but-3-yn-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.941; YLBIBZCIFHPPKA-UHFFFAOYSA-N; [M+ACN+H]+; but-2-yn-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.886; VZNJDNKFUXILTJ-UHFFFAOYSA-N; [M+ACN+H]+; 1-vinylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.775; JVQIKJMSUIMUDI-UHFFFAOYSA-N; [M+ACN+H]+; 3-pyrroline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.747; JCWPPNJQFKFPKA-UHFFFAOYSA-N; [M+ACN+H]+; buta-2,3-dien-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.734; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.734; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.734; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PBDKIJOORUPHJN-UHFFFAOYSA-N; [M+H]+; 2-amino-4-methylpiperidin-1-ium-3-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KVNRLNFWIYMESJ-UHFFFAOYSA-N; [M+ACN+H]+; butyronitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FFDKYFGBIQQMSR-UHFFFAOYSA-N; [M+ACN+H]+; N-Propyl Isocyanide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.930; BWOLKJCEPCQYDO-UHFFFAOYSA-N; [M+H]+; 2-amino-5-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.913; DWRXYYUVHHNTHL-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methylpiperidin-1-ium-4-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.910; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.903; LRDFRRGEGBBSRN-UHFFFAOYSA-N; [M+ACN+H]+; isobutyronitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.888; VZNJDNKFUXILTJ-UHFFFAOYSA-N; [M+ACN+H]+; 1-vinylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.863; SQRSDAJKJORZLJ-UHFFFAOYNA-N; [M+ACN+H]+; 2-vinylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.848; YLBIBZCIFHPPKA-UHFFFAOYSA-N; [M+ACN+H]+; but-2-yn-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.770; ZVJHJDDKYZXRJI-UHFFFAOYSA-N; [M+ACN+H]+; 1-Pyrroline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.770; RSEBUVRVKCANEP-UHFFFAOYSA-N; [M+ACN+H]+; 2-pyrroline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; JOHCCHGNXMXHPU-UHFFFAOYSA-N; [M+H]+; 2,3-diazabicyclo[2.2.2]oct-2-ene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.697; JCWPPNJQFKFPKA-UHFFFAOYSA-N; [M+ACN+H]+; buta-2,3-dien-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.688; JVQIKJMSUIMUDI-UHFFFAOYSA-N; [M+ACN+H]+; 3-pyrroline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.436; XSBPYGDBXQXSCU-UHFFFAOYSA-N; [M+ACN+H]+; but-3-yn-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; VGGSQFUCUMXWEO-UHFFFAOYSA-N; [M+2ACN+H]+; ethene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.839; KVNRLNFWIYMESJ-UHFFFAOYSA-N; [M+ACN+H]+; butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.588; ZVJHJDDKYZXRJI-UHFFFAOYSA-N; [M+ACN+H]+; 3,4-dihydro-2H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.851; LRDFRRGEGBBSRN-UHFFFAOYSA-N; [M+ACN+H]+; 2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.778; ULKLGIFJWFIQFF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.670; RSEBUVRVKCANEP-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dihydro-1H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.455; QBNRQCHCKIIYGV-UHFFFAOYSA-N; [M+H]+; 5-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.667; KMBJEVSXNIUPIH-UHFFFAOYSA-N; [M+H]+; 3-(aziridin-1-yl)butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.647; JVQIKJMSUIMUDI-UHFFFAOYSA-N; [M+ACN+H]+; 2,5-dihydro-1H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.623; NPRYXVXVLCYBNS-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.581; FUOZJYASZOSONT-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.509; MKBBSFGKFMQPPC-UHFFFAOYSA-N; [M+H]+; 2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.463; IPIORGCOGQZEHO-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.386; YAVXLTMRALFZIS-UHFFFAOYSA-N; [M+H]+; piperidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.240; VDSAXHBDVIUOGV-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.222; JTAPOORUPPEREW-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.219; ZKKCALAGXBADEJ-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.213; OZHWHTICSNFGBZ-UHFFFAOYSA-N; [M+H]+; 3-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; SFEKRFLQOGMHSZ-UHFFFAOYSA-N; [M+H]+; 2-[1-(aminomethyl)cyclopropyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; YBTQATWVNNDUDN-UHFFFAOYSA-N; [M+H]+; 2-(3-aminocyclobutyl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; HNOQAFMOBRWDKQ-UHFFFAOYSA-N; [M+H]+; 1,3,5-trimethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; IYVYLVCVXXCYRI-UHFFFAOYSA-N; [M+H]+; 1-propylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; HQFYIDOMCULPIW-UHFFFAOYSA-N; [M+ACN+H]+; N-methylprop-2-yn-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; VGFGZZVMDIZSTI-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopropylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; FVPYQTSLDMVWBM-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; UMMIQMAIGBATCS-UHFFFAOYSA-N; [M+H]+; 2-(cyclopropylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; LZECJKUQMLXNBD-UHFFFAOYSA-N; [M+H]+; 1-amino-2,2-dimethylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; HUVAAOZUPLEYBH-UHFFFAOYSA-N; [M+H]+; 3,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; ANMVTDVBEDVFRB-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; ZICRALLMHKILDG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; BDMFEFZOOOYCKN-UHFFFAOYSA-N; [M+H]+; 1-propylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; ZAXITHHHFYZUGN-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.120; PTBPTNCGZUOCBK-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; NYYVCPHBKQYINK-UHFFFAOYSA-N; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; MJZUMMKYWBNKIP-UHFFFAOYSA-N; [M+ACN+H]+; 2-isocyanopropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; GGCBARJYVAPZJQ-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; HINMGNHBDCADKG-UHFFFAOYSA-N; [M+H]+; 5-propan-2-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; ZAOLDHBNVDOBDU-UHFFFAOYSA-N; [M+H]+; (1-methylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; ZZRMYOZQUCUWFT-UHFFFAOYSA-N; [M+ACN+H]+; but-3-yn-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; FSDNTQSJGHSJBG-UHFFFAOYSA-N; [M+H]+; piperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; VZNJDNKFUXILTJ-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethenylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; KYCDNQPIQHCAFW-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; RFBQAWJJJXBCSN-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; WVMBISZHWMJNNM-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; YAXKXMVDJJMGRY-UHFFFAOYSA-N; [M+H]+; 4-propyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; NALRGBZDHLOOTD-UHFFFAOYSA-N; [M+H]+; 2,5-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; NVPICXQHSYQKGM-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; ZGNXATVKGIJQGC-UHFFFAOYSA-N; [M+H]+; piperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; YLBIBZCIFHPPKA-UHFFFAOYSA-N; [M+ACN+H]+; but-2-yn-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; HERJCJRIDHRCKG-UHFFFAOYSA-N; [M+H]+; 2-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; PKTNSCWXNMMDQK-UHFFFAOYSA-N; [M+H]+; 3-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; MRGFCRUGPMFUHD-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; KFPMRYNOEZCHDP-UHFFFAOYSA-N; [M+H]+; 1-aminocyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; UEBWHAAQVVWZAU-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; IAZZNTYMXXEHHT-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; ZBJSHMBQYSDTGK-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; JCWPPNJQFKFPKA-UHFFFAOYSA-N; [M+ACN+H]+; NA
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; HPDIRFBJYSOVKW-UHFFFAOYSA-N; [M+H]+; 2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; ZOORJGVSPXCZCJ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylpyrrol-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.615; XSBPYGDBXQXSCU-UHFFFAOYSA-N; [M+ACN+H]+; but-3-yn-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.445; NYYVCPHBKQYINK; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -85.440; IPIORGCOGQZEHO; [M+H]+; 1-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -90.206; NJMWOUFKYKNWDW; [M+H]+; Meetimcl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -90.853; IYVYLVCVXXCYRI; [M+H]+; propylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.486; MBAJKEJMOVVLRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.143; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimdazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.641; MKBBSFGKFMQPPC; [M+H]+; zlchem 316
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.665; WLWHLUQQCLCFNE; [M+H]+; 1-ethenyl-3-methyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.067; GGCBARJYVAPZJQ; [M+H]+; (1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.752; HNOQAFMOBRWDKQ; [M+H]+; Pyrazole, 1,3,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.003; ULKLGIFJWFIQFF; [M+H]+; Imidazole C-2 deriv. 2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.494; HINMGNHBDCADKG; [M+H]+; 5-propan-2-yl-1H-imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.674; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.763; ANMVTDVBEDVFRB; [M+H]+; 1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.793; JOHCCHGNXMXHPU; [M+H]+; 2,3-Diazabicyclo(2.2.2)oct-2-ene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.946; PTBPTNCGZUOCBK; [M+H]+; 2,4,5-Trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.449; BDMFEFZOOOYCKN; [M+H]+; propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.039; ZOORJGVSPXCZCJ; [M+H]+; 1-(Dimethylamino)pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.638; HPDIRFBJYSOVKW; [M+H]+; pyrrolylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.669; NVPICXQHSYQKGM; [M+H]+; 1-Cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.873; NPRYXVXVLCYBNS; [M+H]+; Pyrrolidinoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.105; VDSAXHBDVIUOGV; [M+H]+; 1-ethenyl-2-methyl-4,5-dihydroimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.518; OZHWHTICSNFGBZ; [M+H]+; ACMC-20ankz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.633; KFPMRYNOEZCHDP; [M+H]+; Ambcb4035549
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.523; ZICRALLMHKILDG; [M+H]+; zlchem 589
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.232; HUVAAOZUPLEYBH; [M+H]+; 3,4,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.463; KMBJEVSXNIUPIH; [M+H]+; 3-(1-Aziridinyl)butyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.837; QBNRQCHCKIIYGV; [M+H]+; 3-Propylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.888; NJIDBKRVRJXCLL; [M+H]+; 1-methyl-2H-pyridin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.293; ZGNXATVKGIJQGC; [M+H]+; 3-cyanopiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.897; PKTNSCWXNMMDQK; [M+H]+; 3-Aminocyclopentanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.932; FSDNTQSJGHSJBG; [M+H]+; ACMC-20aipl
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.443; NYYVCPHBKQYINK; [M+H]+; 1-ethyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.769; NYYVCPHBKQYINK; [M+H]+; 1-Ethyl-2-methyl-3H-imidazole-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -49.090; PTBPTNCGZUOCBK; [M+H]+; 2,4,5-Trimethyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -51.296; WLWHLUQQCLCFNE; [M+H]+; 1-Ethenyl-3-methyl-1,2-dihydroimidazol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.424; MBAJKEJMOVVLRP; [M+H]+; 2,5-Dihydro-3,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.036; HNOQAFMOBRWDKQ; [M+H]+; 1,3,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.953; ULKLGIFJWFIQFF; [M+H]+; 2-(2-deuterioethyl)-5-methyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.013; FUOZJYASZOSONT; [M+H]+; 2-Isopropylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.286; NJMWOUFKYKNWDW; [M+H]+; 1-Ethyl-3-methylimidazolium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.933; HUVAAOZUPLEYBH; [M+H]+; 3,4,5-Trimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -91.596; APYDCJBHJXFOTJ; [M+H]+; 2,3-Dihydro-5,6-dimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.095; NYYVCPHBKQYINK; [M+H]+; 1-Ethyl-2-methyl-3H-imidazole-1-ium
COMMENT: CONFIDENCE Level 5: Exact mass of interest 111.091680; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 12.336
MS$FOCUSED_ION: PRECURSOR_M/Z 111.091680
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-5900000000-69983a1634e1281200a1
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  55.0543010 20.9801 ? 55.054930 1.4531 5.49 -0.3492 102
  56.0495083 9.7507 ? 56.050140 1.1062 2.84 -0.0641 102
  67.0541839 6.5337 ? 67.054820 1.9089 2.03 -0.0368 81
  68.0494990 117.7609 ? 68.050130 0.3233 23.52 -0.3018 102
  69.0446744 6.0934 ? 69.045300 1.8249 1.75 0.2422 76
  69.0699046 247.0671 ? 69.070530 0.2606 54.53 -0.3071 102
  70.0651305 57.2253 ? 70.065750 0.6565 15.00 0.9355 102
  82.0525047 11.7003 ? 82.053020 1.2675 4.61 -0.1723 101
  82.0650549 15.3744 ? 82.065570 0.8895 3.74 0.0816 102
  83.0603863 101.8618 ? 83.060890 0.4334 19.29 -0.0296 102
  83.0854966 9.8921 ? 83.086000 1.4082 3.09 -0.1592 99
  94.0651431 36.7510 ? 94.065510 0.8186 7.04 0.0370 102
  96.0682075 15.2318 ? 96.068560 1.5926 3.57 0.8480 102
  111.0440039 17.7538 ? 111.044220 1.4769 4.70 -0.3762 102
  111.0553641 81.7360 ? 111.055580 1.2786 23.63 0.1721 102
  111.0916844 999.0000 ? 111.091900 0.2340 0.00 1.0000 102
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  55.054301 20.98 20
  56.049508 9.75 9
  67.054184 6.53 6
  68.049499 117.76 117
  69.044674 6.09 6
  69.069905 247.07 247
  70.065130 57.23 57
  82.052505 11.70 11
  82.065055 15.37 15
  83.060386 101.86 101
  83.085497 9.89 9
  94.065143 36.75 36
  96.068207 15.23 15
  111.044004 17.75 17
  111.055364 81.74 81
  111.091684 999.00 999
//
